The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma.
- DOI
- 10.1183/09031936.02.00016502
- Published
- 2002 Nov
- Container
- The European respiratory journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/09031936.02.00016502,
title = {The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma.},
author = {Buhl R and Hanf G and Solèr M and Bensch G and Wolfe J and Everhard F and Champain K and Fox H and Thirlwell J},
year = {2002},
journal = {The European respiratory journal},
doi = {10.1183/09031936.02.00016502},
url = {https://doi.org/10.1183/09031936.02.00016502}
}RIS
TY - JOUR TI - The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. AU - Buhl R AU - Hanf G AU - Solèr M AU - Bensch G AU - Wolfe J AU - Everhard F AU - Champain K AU - Fox H AU - Thirlwell J PY - 2002 JO - The European respiratory journal DO - 10.1183/09031936.02.00016502 UR - https://doi.org/10.1183/09031936.02.00016502 ER -
APA
R, B., G, H., M, S., G, B., J, W., F, E., K, C., H, F., & J, T. (2002). The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma.. The European respiratory journal. https://doi.org/10.1183/09031936.02.00016502
Source records
- pubmed · retrieved 2026-11-10T11:38:38.281Z